Q7SSI0 (Q7SSI0_9HIV1) Human immunodeficiency virus 1
Protease UniProtKBInterProInteractive Modelling
99 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
25 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Kinetics, stability, and structural changes in high resolution crystal structures of HIV-1 protease… |
Heteromer P04587; | 1×SO4; 1×DMS; 1×MK1; 2×ACY; 1×GOL; | ||||
Assess | ||||||
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug amprenavir |
Heteromer Q7SSE3; | 1×478; 17×IOD; 2×GOL; | ||||
Assess | ||||||
HIV-1 protease complexed with gem-diol-amine tetrahedral intermediate NLLTQI |
Heteromer P04587; | 1×NA; 3×CL; 1×GOL; | ||||
Assess | ||||||
HIV-1 protease mutant I54V complexed with gem-diol-amine intermediate NLLTQI |
Heteromer P04587; | 1×NA; 3×CL; | ||||
Assess | ||||||
Ultra-high resolution X-ray crystal structure of HIV-1 protease V32I mutant with TMC114 (darunavir)… | homo-2-mer | 3×CL; 2×017; 1×DMS; | ||||
Assess | ||||||
Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir | homo-2-mer | 3×SO4; 1×ROC; | ||||
Assess | ||||||
Crystal structure analysis of HIV-1 protease mutant V82A with a potent non-peptide inhibitor (UIC-9… | homo-2-mer | 1×CL; 4×PO4; 1×DMS; 6×ACY; 1×GOL; 1×017; | ||||
Assess | ||||||
Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir | homo-2-mer | 2×CL; 1×NA; 1×SO4; 1×ROC; | ||||
Assess | ||||||
Wild Type HIV-1 Protease with Antiviral Drug Saquinavir | homo-2-mer | 1×ROC; 2×FMT; 2×SO4; | ||||
Assess | ||||||
Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir | homo-2-mer | 1×ROC; 2×ACY; 2×GOL; 1×SO4; | ||||
Assess | ||||||
Crystal structure of M46L mutant of HIV-1 protease complexed with TMC114 (darunavir) | homo-2-mer | 2×CL; 2×017; 1×DMS; | ||||
Assess | ||||||
Crystal structure analysis of HIV-1 protease mutant I84V with a inhibitor saquinavir | homo-2-mer | 2×NA; 3×CL; 1×ROC; 1×ACY; 2×GOL; | ||||
Assess | ||||||
Crystal structure of wild-type HIV-1 protease with novel tricyclic P2-ligands GRL-0739A | homo-2-mer | 1×G79; 2×CL; 3×ACT; 1×NA; 2×GOL; | ||||
Assess | ||||||
Structure of Unliganded HIV-1 Protease F53L Mutant | homo-2-mer | |||||
Assess | ||||||
Wild-type HIV-1 Protease in complex with potent inhibitor GRL06579 | homo-2-mer | 3×CL; 2×NA; 1×GRL; 1×GOL; | ||||
Assess | ||||||
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P21212 | homo-2-mer | 1×NA; 2×CL; 1×017; 1×GOL; 1×ACT; | ||||
Assess | ||||||
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug darunavir in space group P212121 | homo-2-mer | 2×017; 1×PO4; 10×IOD; | ||||
Assess | ||||||
HIV-1 protease with TMC-126 | homo-2-mer | 1×DJR; | ||||
Assess | ||||||
HIV-1 protease triple mutants V32I, I47V, V82I with GRL-011-11A (a methylamine bis-Tetrahydrofuran … | homo-2-mer | 4×FMT; 1×4UY; 1×GOL; | ||||
Assess | ||||||
Crystal structure analysis of HIV-1 protease mutant I84V with a potent non-peptide inhibitor (UIC-9… | homo-2-mer | 3×CL; 1×NA; 1×017; | ||||
Assess | ||||||
Room temperature X-ray structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral … | homo-2-mer | 1×P3V; | ||||
Assess | ||||||
HIV-1 protease triple mutants V32I, I47V, V82I with antiviral drug saquinavir | homo-2-mer | 2×ROC; 1×ACT; | ||||
Assess | ||||||
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with amprenavir at p… | homo-2-mer | 1×478; | ||||
Assess | ||||||
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with darunavir at pH… | homo-2-mer | 1×017; | ||||
Assess | ||||||
Joint X-ray/neutron structure of HIV-1 protease triple mutant (V32I,I47V,V82I) with tetrahedral int… | homo-2-mer | 1×KVS; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1aid.1.A | homo-2-mer | 0.83 | 1×THK; | 93.94 | ||
Assess |